Apollomics Inc.
corporate_fare Company Profile
Apollomics Inc. (NASDAQ:APLM) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 11 items for APLM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-17, rated 9/10. Across its 11 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for APLM spans 4, SCHEDULE 13D/A, 6-K, 20-F.
Recent high-impact activity:
- CFO Invests $400K in Private Placement, Boosting Insider Confidence
- CEO Chen Acquires 536,667 Shares in $5.55M PIPE, Boosting Stake to 49.76%
- $10M Private Placement Priced at $15/Share, Insiders Participate
- Apollomics Regains Nasdaq Compliance, Delisting Threat Lifted
- Apollomics Terminates Key Partnership Due to Material Breach, Initiates Dispute Resolution
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for APLM, detected from its recent SEC filings · based on capital-structure filings through 2026-09-08.
279,775 PIPE Shares Registered for Resale · Selling Securityholders Identified
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
APLM files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.